Nistico Robert's Form 4 filing
Endovia Health Sciences, Inc. (EDVA) · filed Jun 16, 2022
- Accession no.
- 0001731122-22-001089
- Filed
- Jun 16, 2022
- Trade date
- Jun 15-16, 2022
- Filing delay
- 1 day
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 5 non-derivative transactions and 0 derivative transactions. Open-market purchases total $6.88K. It was filed 1 day after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Nistico RobertCIK 0001797597 | Director, Officer (CEO and Chairman) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jun 15, 2022 | Common Stock | PPurchaseAcquired | +315 | $1.82 | +$573.3 | 1,323,385 | Direct | |
| Jun 15, 2022 | Common Stock | PPurchaseAcquired | +685 | $1.83 | +$1,253.55 | 1,324,070 | Direct | |
| Jun 16, 2022 | Common Stock | PPurchaseAcquired | +1,000 | $1.69 | +$1,690 | 1,325,070 | Direct | |
| Jun 16, 2022 | Common Stock | PPurchaseAcquired | +1,000 | $1.67 | +$1,670 | 1,326,070 | Direct | |
| Jun 16, 2022 | Common Stock | PPurchaseAcquired | +1,000 | $1.69 | +$1,690 | 1,327,070 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.